4-OH-E1 (male)

Optimal result: 0 – 0.8 ng/mg

This particular estrogen metabolite appears to be more abundant among men diagnosed with prostate cancer [1]

Possible treatment (please discuss with your doctor before starting any type of treatment)

  • Improve methylation by adding cofactors (B12, folate) or methyl donors (betaine, dimethyl glycine)
  • Consider genetic testing for COMT and CYP1B1 activity, particularly if positive family history
  • Reduce stress: COMT is involved in the metabolism of epinephrine, reducing availability for estrogen metabolism
  • Increase inhibitors of CYP1B1
    • Grapefruit
    • Ginseng
  • Avoidance of CYP1B1 inducers
    • Polycyclic aromatic hydrocarbons
  • Evaluate methylation activity:
    • Serum Homocysteine
    • Serum B12 or methylation
    • Urinary FIGLU
    • Urinary xanthurenate
  • Other potential protective factors:
    • Glutathione (reduction of estrogen quinones)
    • Resveratrol (prevents estrogen quinone formation)
    • Selenium, zinc, magnesium

Generally no treatment recommended

A very carcinogenic estrogen metabolite, levels low in the reference range are desirable. Additional magnesium, liver support, and methylation support may help decrease 4-OH-E1 levels.

4-OH-E1 is referred to as the “bad” estrogen, along with 16-OH-E1.

  • It is a minor pathway of estrogen metabolism.
  • It may also enhance cancer development.
  • It may directly damage DNA by causing breaks in the molecular strands of DNA. 

4-Hydroxyestrones have the ability to convert to metabolites that react with DNA and cause mutations that can be carcinogenic. It is also present in greater quantities in patients deficient in methionine and folic acid. 

References:

  • Spink BC, Fasco MJ, Gierthy JF, Spink DC. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells. J Cell Biochem. Sep 1 1998;70(3):289- 296.
  • Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA. Sep 3 1996;93(18):9776-9781.
  • Yang L, Gaikwad NW, Meza J, et al. Novel biomarkers for risk of prostate cancer: results from a case-control study. Prostate. Jan 1 2009;69(1):41-48.
  • Castagnetta LA, Granata OM, Traina A, et al. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin Cancer Res. Oct 2002;8(10):3146-3155.
  • https://www.sciencedaily.com/releases/2010/04/100419150813.htm
4-OH-E1 (male)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond 4-OH-E1 (male) — 10,000+ markers explained
One 4-OH-E1 (male) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro